OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) Director Thomas Kosasa bought 268,817 shares of the stock in a transaction on Monday, May 18th. The shares were acquired at an average cost of $0.93 per share, for a total transaction of $249,999.81. Following the completion of the transaction, the director directly owned 16,930,144 shares of the company’s stock, valued at approximately $15,745,033.92. The trade was a 1.61% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Thomas Kosasa also recently made the following trade(s):
- On Thursday, April 23rd, Thomas Kosasa bought 280,898 shares of OneMedNet stock. The shares were acquired at an average cost of $0.89 per share, for a total transaction of $249,999.22.
OneMedNet Price Performance
OneMedNet stock opened at $0.85 on Friday. The company has a market capitalization of $46.21 million, a price-to-earnings ratio of -12.13 and a beta of 1.25. OneMedNet Corporation has a one year low of $0.31 and a one year high of $4.22. The company’s fifty day moving average price is $0.90 and its two-hundred day moving average price is $1.05.
Hedge Funds Weigh In On OneMedNet
Several hedge funds have recently bought and sold shares of ONMD. Virtu Financial LLC acquired a new stake in shares of OneMedNet in the fourth quarter valued at about $48,000. State Street Corp grew its position in shares of OneMedNet by 41.5% in the fourth quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after purchasing an additional 34,200 shares during the last quarter. Jane Street Group LLC acquired a new stake in shares of OneMedNet in the fourth quarter valued at about $119,000. HRT Financial LP acquired a new stake in shares of OneMedNet in the fourth quarter valued at about $32,000. Finally, Exencial Wealth Advisors LLC grew its position in shares of OneMedNet by 1.3% in the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after purchasing an additional 45,401 shares during the last quarter. 0.95% of the stock is owned by institutional investors and hedge funds.
OneMedNet Company Profile
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
See Also
- Five stocks we like better than OneMedNet
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
